RxDoctor Payments Data

Rebecca Khan

Obstetrics & Gynecology · Chesapeake, VANPI 1770558504

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Roche Diagnostics Corporation at 52.4% of the total. 2023 is the largest year on record at $1,169, 3.7 times the $319 reported in 2019.

$2,232in general payments, 2019–2025

Across 69 payments — averaging $32.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$1K
  • AbbVie$397
  • Daiichi Sankyo Inc.$80
  • Bayer$77
  • Minerva Surgical, Inc$64
  • Therapeuticsmd, Inc.$62
  • plus $383 from 14 others

What the payments were for

  • Speaking & faculty fees$1,16952%
  • Food & beverage$1,03546%
  • Education$281%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,232 in reported general payments places this provider in the 80th percentile of 992 obstetrics & gynecology providers in Virginia.

See all obstetrics & gynecology providers in Virginia →

Other obstetrics & gynecology in Chesapeake

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →